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Abstract The biosynthesis of natural products by heterolo-
gous expression of biosynthetic pathways in amenable pro-
duction strains enables biotechnological access to a variety
of valuable compounds by conversion of renewable resources.
Pseudomonas putida has emerged as a microbial laboratory
work horse, with elaborated techniques for cultivation and
genetic manipulation available. Beyond that, this bacterium
offers several particular advantages with regard to natural
product biosynthesis, notably a versatile intrinsic metabolism
with diverse enzymatic capacities as well as an outstanding
tolerance to xenobiotics. Therefore, it has been applied for
recombinant biosynthesis of several valuable natural products.
This review provides an overview of applications of P. putida
as a host organism for the recombinant biosynthesis of such
natural products, including rhamnolipids, terpenoids,
polyketides and non-ribosomal peptides, and other amino
acid-derived compounds. The focus is on de novo natural
product synthesis from intrinsic building blocks by means of
heterologous gene expression and strain engineering. Finally,
the future potential of the bacterium as a chassis organism for
synthetic microbiology is pointed out.
Keywords Pseudomonas putida . Heterologous pathway
expression . Recombinant biosynthesis . Natural products
Introduction
For the biotechnological production of natural products,
engineered bacteria generally offer several advantages over
the original producers. As opposed to many natural producers,
typically applied engineered bacteria are characterized by easy
handling regarding laboratory cultivation which is the prereq-
uisite for biotechnological applications. In addition, indepen-
dence of natural regulation systems usually immanent in the
original producer permits controlled biosynthesis and the con-
struction of hyper-production strains. Furthermore, usage of
non-harmful generally recognized as safe (GRAS)-certified
strains such as Pseudomonas putida KT2440 allows studies
in many laboratories as well as industrial-scale production.
Applying well-established and genetically accessible labora-
tory work horses moreover allows for genetic manipulation of
biosynthetic modules in order to direct biosynthesis to desired
compounds.
P. putida has emerged as one of the laboratory work horses
matching the abovementioned advantages and offering specif-
ic features of particular interest beyond that. In recent decades,
this Gram-negative soil bacterium has been virtually
Bdomesticated^ by means of synthetic biology, as excellently
reviewed by Nikel et al. (2014). Plenty of tools for genetic
manipulation and gene expression are available including nu-
merous inducible promoter systems (and corresponding in-
ducer compounds) such as native Pm/XylS (m-toluate) (de
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et al. 1993), and PalkB/AlkS (short-chain alkanes) (Panke
et al. 1999) as well as the non-native systems Plac (IPTG)
(Baumberg et al. 1980), Ptac (IPTG) (Bagdasarian et al.
1983), PT7 (IPTG via Plac) (Troeschel et al. 2012), PT7 (m-
toluate via Pm/XylS) (Herrero et al. 1993), NagR/PnagAa
(salicylate) (Hüsken et al. 2001), rhaPBAD (Rhamnose) (Jeske
and Altenbuchner 2010), and Ptet (tetracycline) (Chai et al.
2012). The genomes of important strains such as P. putida
KT2440 (Nelson et al. 2002) or S12 (Kuepper et al. 2015)
are fully sequenced, providing the basis for understanding
metabolic networks (Nelson et al. 2002; Puchałka et al.
2008; Wu et al. 2011) and sophisticated strain development
approaches (Martínez-García et al. 2014b). Due to its relative-
ly high guanine-cytosine (GC) content (61.5 %), P. putida is
suitable for heterologous expression of genes from GC-rich
bacterial clades like actinobacteria or myxobacteria that are
especially rich in secondary metabolite biosynthesis gene
clusters. On the level of biosynthesis, P. putida offers a wealth
of cofactors especially for oxidoreductases (Blank et al. 2010;
Tiso et al. 2014) and a versatile metabolism with diverse in-
trinsic enzymatic capacities for production purposes (Nelson
et al. 2002), while at the same time, a rather Bclean^ back-
ground simplifies the detection of many heterologously syn-
thesized metabolites (Martinez et al. 2004; Stephan et al.
2006). Moreover, the bacterium exhibits a high tolerance to-
wards xenobiotics including antibiotics and organic solvents.
This extraordinary feature is the result of complex adaptations
such as effective efflux systems which are typically activated
in presence of xenobiotics (Fernández et al. 2009; Simon et al.
2014), rendering it an ideal producer of such compounds and
an especially suitable organism for production processes in
two-phase system (Heipieper et al. 2007).
This review covering the literature which has appeared
untilMarch 2015 aimed to summarize applications ofP. putida
as a host organism for recombinant natural product biosynthe-
sis by means of heterologous gene expression and strain en-
gineering. The focus is on bioconversion of basic nutrients for
de novo synthesis of complex natural products from intrinsic
building blocks (Fig. 1). Biotransformations, i.e., the turnover
of preformed substrates into products by one or few recombi-
nant biocatalysts (Berger 1995; Tiso et al. 2014), using
P. putida as a host are important applications as well which
have been recently excellently reviewed elsewhere (Poblete-
Castro et al. 2012; Tiso et al. 2014) and are thus not covered
by this review.
Secondary metabolites of P. putida
Besides the utilization of P. putida for recombinant natural
product biosynthesis, which is the main focus of this review,
it is worth mentioning that strains of this organism naturally
produce secondary metabolites of biotechnological interest.
Particularly noteworthy are the polymers alginate (Chang
et al. 2007; Tiso et al. 2014) and medium-chain length
polyhydroxyalkanoates (PHA) (Valentin et al. 1998). The lat-
ter attracted special attention due to their physical and material
properties; they are thermoplastic and/or elastomeric, are in-
soluble in water, are enantiomerically pure, are non-toxic, ex-
hibit a high degree of polymerization, and are therefore
discussed as alternative biodegradable polymers for biotech-
nological industry (Steinbüchel and Lütke-Eversloh 2003).
This polyester of hydroxy fatty acids is synthesized by PHA
synthase, an α/β-hydrolase-like enzyme, from R-3-
hydroxyacyl-CoA which is supplied by several metabolic
pathways (Rehm et al. 2001; Verlinden et al. 2007). The mo-
nomeric R-3-hydroxy fatty acids are in turn obtained from
PHA hydrolysis to provide a chiral building block of pharma-
ceutical relevance (Lee et al. 1999; Yuan et al. 2008;
O’Connor et al. 2013). Due to the material’s interesting prop-
erties, PHA synthesis was object of several studies concerning
yield optimization and tailoring the polymer by metabolic
engineering (Huijberts and Eggink 1996; Steinbüchel and
Lütke-Eversloh 2003; Tiso et al. 2014; Vo et al. 2015).
Very recently, a rhizosphere soil bacterium identified as
P. putida was shown to produce the antibiotic and antitumor
phenazine derivate 5-methyl-phenazine-1-carboxylic acid
(Kennedy et al. 2015).
Furthermore, different P. putida strains are known to pro-
duce non-ribosomal peptides (Gross and Loper 2009), which
were, however, not yet intensely studied in terms of biotech-
nological applications. Very common among pseudomonads
is the synthesis of the fluorescent siderophore pyoverdine,
which is discussed for different applications such as plant
growth promotion (Glick 2012; Saha et al. 2015). P. putida
strains 267, PCL1445, and W15Oct28 or strain RW10S2 are
moreover reported to release lipopeptide biosurfactants with
antimicrobial properties, namely putisolvins and a viscosin-
like peptide (Kuiper et al. 2004; Kruijt et al. 2009; Rokni-
Zadeh et al. 2012; Ye et al. 2014). In silico genome mining
of additional secondary metabolite clusters for P. putida
KT2440 with antiSMASH 3.0 (Weber et al. 2015) revealed
a gene cluster comprising another non-ribosomal peptide syn-
thetase gene (cluster location 4,798,235–4,851,188 nt, NRP
gene PP4243) and two clusters for biosynthesis of bacterio-
cins (1,126,477–1,137,310 and 2,738,633–2,749,466 nt),
members of PiPPs (ribosomally synthesized and post-
translationally modified peptides). An analogous analysis
of the P. putida S12 chromosome and megaplasmid
pTTS12 likewise unveiled the presence of two clusters
for bacteriocin biosynthesis (951,794–962,627 and 4,
313,737–4,324,570 nt), furthermore a type I polyketide
synthase (3,653,938–3,701,437 nt, polyketide synthase
(PKS) gene RPPX16405), but no further non-ribosomal
peptide synthesis-related genes besides the cluster for
pyoverdine synthesis.
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In the following, different groups of natural products syn-
thesized in recombinant P. putida will be discussed, namely
rhamnolipids, terpenoids, polyketides and non-ribosomal pep-
tides as well as hybrids thereof, and further amino acid-
derived compounds (Fig. 1). All products together with rele-
vant characteristics of the respective studies are summarized
in Table 1; selected examples are shown in Fig. 2 to illustrate
diversity of compounds and architecture of cognate biosyn-
thetic gene clusters.
Rhamnolipids
Rhamnolipids are currently considered as the best studied rep-
resentatives of bacterial biosurfactants (Müller et al. 2012), a
class of metabolites with most various chemical compositions
produced by different bacteria and fungi (Hausmann and
Syldatk 2014). Due to excellent surfactant properties, low
toxicity, high biodegradability, and antimicrobial effects,
rhamnolipids are discussed for various applications, e.g., in
cleaning agents, cosmetics, food industry, biocontrol, and soil
remediation (Fracchia et al. 2014). Rhamnolipids consist of a
hydrophobic domain with generally two molecules of hy-
droxy fatty acids forming 3-(hydroxyalkanoyloxy)alkanoic
acid (HAA) and a hydrophilic part of one or two molecules
of the sugar rhamnose, thus forming mono-rhamnolipids and
di-rhamnolipids, respectively (Abdel-Mawgoud et al. 2010).
At least two enzymes are required for the biosynthesis of
rhamnolipids from the precursor metabolites dTDP-
rhamnose and hydroxy fatty acid-ACP: (i) the acyltransferase
RhlA for generation of HAA and (ii) the rhamnosyltransferase
RhlB for glycosidic bond formation. For synthesis of di-
rhamnolipids, a second molecule of activated rhamnose is
added to mono-rhamnolipids by the rhamnosyltransferase
RhlC (Abdel-Mawgoud et al. 2011).
The opportunistic human pathogen Pseudomonas
aeruginosa is the best-studied organism for rhamnolipid
production. Although nowadays different non-pathogenic
bacteria are described to be capable of rhamnolipid formation
(Toribio et al. 2010), among them the β-proteobacterium
Burkholderia glumae (Costa et al. 2011; Voget et al. 2015),
the marine Thermus sp. (Rezanka et al. 2011), and some
strains from the P. putida group (Tuleva et al. 2002; Martí-
nez-Toledo et al. 2006), most studies concerning optimization
of rhamnolipid production are performed with P. aeruginosa
(Müller et al. 2010; Müller et al. 2012). Recombinant expres-
sion of rhamnolipid biosynthesis pathways in closely related
P. putida offers a promising alternative.
Mono-rhamnolipid (Fig. 1) production in P. putida strains
by expression of rhlAB from diverse strains of P. aeruginosa
and the product’s extracellular accumulation was reported by
several groups at gram scale. Different promoters were eval-
uated for expression of the ca. 2-kb operon, namely the syn-
thetic hybrid promoter Ptac, (Ochsner et al. 1995; Wittgens
et al. 2011; Setoodeh et al. 2014), a set of completely synthetic
promoters in comparison to Ptac (Blank et al. 2013), or the
native regulation system via coexpression of the cognate
autoinducer-dependent transcription factor/autoinducer syn-
thase pair RhlR/RhlI from P. aeruginosa (Cha et al. 2008;
Cao et al. 2012). Metabolic network analysis identified the
PHA formation (see above) via PHA synthases PhaC1/C2 as
a competitor for the precursor hydroxy fatty acid-ACP. Con-
sequential deletion of phaC1 was proven to be beneficial for
rhamnolipid product accumulation (Wittgens et al. 2011).
Remarkably, a rhamnolipid-producing P. putida strain with
genome-integrated rhlABRI could be applied for remediation
of soil contaminated with PAH (polycyclic aromatic hydrocar-
bons), whereat interestingly P. putida itself was shown to be
unable to degrade PAH, but the secreted biosurfactants vastly
Fig. 1 Hitherto described
utilization of Pseudomonas
putida as cell factory for the




blocks from intrinsic metabolism.
Indicated examples are from left
to right p-coumarate,
pretubulysin A, mono-
rhamnolipid, and geranic acid
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Table 1 Natural products synthesized in P. putida by heterologous gene expression and strain engineering
Producta Native producerb P. putidac Expression strategyd Yielde Reference
Rhamnolipids (RL)
Mono-RL P. aeruginosa KT2442 Ptac, rhlAB (2.2 kb), pl 0.60 g/l
C yield 0.17
Ochsner et al. 1995
KT2440 Ptac, rhlAB (2.2 kb), pl 0.57 g/l Setoodeh et al. 2014
KT2440 Ptac, rhlAB (2.3 kb), pl., *ΔphaC1 1.5 g/l
C yield 0.23
Wittgens et al. 2011
KT2440 Ptac*/Psynthetic
1, rhlAB (2.3 kb), pl.,
* ΔphaC1
up to 12.5 g/l
*C yield 0.23
Blank et al. 2013
KCTC 1067 Pnative(RhlRI), rhlABRI (4 kb), pl. 7.3 g/l
C yield 0.17
Cha et al. 2008





rhlAB/rhlABM (2.3 kb/3.6 kb syn op),




Schaffer et al. 2012
Mono- and
di-RL
B. glumae KT2440 Ptac, rhlAB(C) (3.4 kb), pl 80 mg/l
(mono-RL),
50 mg/l (mixture)
Blank et al. 2013
Terpenoids
Geranic acid O. basilicum DSM
12264
rhaPBAD, ges + *MVA genes of M.
xanthus (~8.5 kb syn op), pl
193 mg/l,
BR FB
Mi et al. 2014
Zeaxanthin P. ananatis KT2440 rhaPBAD, crtEIBYZ + *isoprenoid
genes of E. coli (~8.5 kb syn op), pl
239 mg/l, FB Beuttler et al. 2011
β-Carotene
Zeaxanthin
P. ananatis KT2440 PT7, crtEΔXYIBZ, (6.9 kb), chr 0.2 mg/gCDW Loeschcke et al. 2013
Polyketides/Non-ribosomal peptides
2,4-DAPG P. fluorescens KT2440 Pnative/Pchr of P. putida, phlACBDE
(6.5 kb), chr
n.d. Martinez et al. 2004
Flaviolin S. cellulosum KT2440 Pm, rppA (1.1 kb), pl. ~6 mg/l Gross et al. 2006a
β-Lactam DAC L. lactamgenus IFO14164 Plac, pcbABCcefEFDbla (16 kb), pl ~2 mg/l Kimura et al. 1996
Serrawettin W1 S. marcescens KT2440 Ptac, swrW (4 kb), pl n.d. Thies et al. 2014;
unpublished
Myxochromide S S. aurantiaca KT2440 Pm, mchABC (30 kb), chr 40 mg/l Wenzel et al. 2005
Myxothiazol A S. aurantiaca KT2440 Pm, mtaBCDEFG (60 kb), chr,
*mm-CoA+
0.6 mg/l Gross et al. 2006b,
Perlova et al. 2006
(Tyrosin)
Pretubulysin A
Cystobacter sp. KT2440 Pnative/Ptet, tubAorf2tubZorf1tubBCDEF
orf17orf18 (~40 kb), chr
1.76 μg/l Chai et al. 2012
Syringolin A P. syringae P3 Pnative, sylABCDE (22 kb), cos n.d. Ramel et al. 2009
Glidobactin A P. luminescens P3 Pnative, plu1881-1877 (19 kb), cos n.d. Dudnik et al. 2013
Prodigiosin S. marcescens KT2440 PT7, pigABCDEFGHIJKLMN
(22 kb), chr
0.5 mg/gCDW Loeschcke et al. 2013
Amino acid-derived compounds
Phenol P. agglomerans S12 NagR/pNagAa, tpl (1.4 kb), pl.,
*random mutagenesis
9.2 mM,
C yield 0.07 biphasic
BR FB
Wierckx et al. 2005
t-Cinnamate R. toruloides S12 Ptac, pal (2.5 kb), pl.,
*random mutagenesis
5.4 mM, BR FB
C yield 0.07
Nijkamp et al. 2005
p-Coumarate R. toruloides S12 Ptac, pal (2.5 kb), pl., *random muta-
genesis: Phe auxotrophy, Δfcs
1.7 g/l, BR FB
C yield 0.04





S12 NagR/pNagAa, pal pdc (3 kb syn op),
pl., *Δfcs Δsmo
21 mM, Cmol 0.04,
biphasic BR FB
Verhoef et al. 2009
p-Hydroxy-
benzoate
R. toruloides S12 Ptac, pal (2.5 kb), pl., *ΔpobA 1.8 g/l, BR FB
C yield 0.11
Verhoef et al. 2007
p-Hydroxy-
benzoate




Verhoef et al. 2010
6200 Appl Microbiol Biotechnol (2015) 99:6197–6214
increased the degradation by native soil microorganisms (Cao
et al. 2012).
Mono-rhamnolipids can be easily converted to di-
rhamnolipids (Fig. 2, 1), as described above, via the activity
of the second rhamnosyltransferase RhlC to formmore hydro-
philic biosurfactants. Nonetheless, there are only two reports
describing the heterologous expression of all three RL-
synthesis genes in P. putida. Expression of rhlABC from
P. aeruginosa yielded up to 113 mg/l/OD600 using PHA-
deficient P. putida GPp104 (Schaffer et al. 2012). Notably,
di-rhamnolipid concentration in the culture supernatant was
increased when PA1131, a putativemajor facilitator superfam-
ily transporter that is organized in one operon with rhlC, was
coexpressed. Thus far, the mechanism of rhamnolipid secre-
tion is described neither for heterologous production strains
nor for the native producers, and it remains unclear if PA1131
contributes actively to the secretion of the products or if there
are currently unknown regulatory effects. Blank et al. (2013)
demonstrated that rhamnolipid properties may vary with the
origin of the biosynthetic genes applied. They reported the
production of both mono- and di-rhamnolipids expressing
rhlAB(C) genes from B. glumae PG1 controlled by Ptac, yield-
ing 80 mg/l of pure mono-rhamnolipids and 50 mg/l of a
mixture, respectively. Compared to P. aeruginosa, B. glumae
naturally produces more hydrophobic rhamnolipids with
higher average fatty acid chain length. Remarkably, compara-
ble fractions were produced upon expression of the respective
genes in P. putida KT2440.
The here reviewed studies from both academia and indus-
try illustrate that P. putida has emerged as an excellent plat-
form for recombinant rhamnolipid production and may thus
replace the pathogenic P. aeruginosa in future rhamnolipid
production processes. An additional advantage of P. putida
is its resistance to very high concentrations of rhamnolipids
showing little change in growth rate if exposed to concentra-
tions up to 90 g/l (Wittgens et al. 2011), suggesting that even
higher yields are feasible. Crucial factors for optimization of
recombinant rhamnolipid production in P. putida include the
choice of an appropriate promoter and the increase in biosyn-
thetic flux toward the product, e.g., by deletion of the compet-
ing PHA pathway.
Terpenoids
Terpenoids constitute one of the most diverse groups of sec-
ondary metabolites in nature, and many of them find
Table 1 (continued)
Producta Native producerb P. putidac Expression strategyd Yielde Reference
p-Hydroxy-
benzoate
R. toruloides S12 Ptac, pal (2.5 kb), pl.,
*Δgcd, xylAB_FGH+
C-yield 0.16 chemostat Meijnen et al. 2011b




Metagenome KT2440 eDNA fragment of 28.8 kb, cos n.d. Craig et al. 2010
Phenazine PCA P. fluorescens WCS358r Ptac, phzABCDEFG (6.8 kb), chr n.d. Glandorf et al. 2001
Pyocyanin P. aeruginosa KT2440 NagR/pNagA, phzA1B1C1D1E1F1G1
(6.7 kb), phzMS (2.2 kb syn op), pl.
45 mg/l Schmitz et al. 2015
MEA A. thaliana S12 NagR/pNagA, sdc-tr (1.3 kb), pl.,
*ΔeutBC
2.6 mM Foti et al. 2013
Cyanophycin Synechocystis sp. KT24402/
GPp104
Pnative/Plac, cphA, (3.3 kb), pl
211 % of CDW Aboulmagd et al. 2001
Synechocystis sp. KT2440/
GPp1043
Pnative/Plac, cphA (3.3 kb), pl.
310 % of CDW Voss et al. 2004
Anabaena spec. KT2440/
GPp1044
Pnative/Plac, cphA1 (3.3 kb), pl
424% of CDW Voss et al. 2004
Synechocystis sp. KT2440/
GPp1045
Pnative/Plac, cphA (3.2 kb), pl
59.7 % of CDW Voss et al. 2004
Synechococcus spec. KT2440/
GPp1046
Pnative/Plac, cphA (3 kb), pl
617.5 % of CDW Voss et al. 2004
Citrulline-
cyanophycin
Synechocystis sp. ATCC 4359 Pnative/Plac, cphA, (3.3 kb), pl 43.4 % of CDW Wiefel et al. 2011
Synthesized products (a ) are listed together with the native producers whose corresponding biosynthetic genes were employed (b ). The P. putida strains
used for production (c ) and the respective expression strategies (d ) are indicated. Here, applied promoters, expressed genes and their size, as well as the
mode of maintenance within the host are named: plasmid (pl.), cosmid (cos), or chromosome (chr). Additional strain engineering is indexed (*). Product
yields are given in units as stated in the original publications, carbon yield (Cmolproduct/Cmolsubstrate) is abbreviated as C yield, if stated (
e ). The applied
production processes other than shake flask batch cultivations are indicated.
FB fed batch, BR bioreactor cultivation
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applications in areas such as human health and nutrition. They
are synthesized from universal C5 isoprene precursors
isopentenyl diphosphate (IPP) and its isomer dimethylallyl di-
phosphate (DMAPP). Terpene synthases cyclize poly-isoprene
units or produce linear compounds thereof. Typically, the syn-
thase reaction is followed by decoration of the molecule, car-
ried out by terpene-modifying enzymes such as cytochrome
P450 monooxygenases (Bouvier et al. 2005; Cane and Ikeda
2012). Much effort has been devoted toward their production
in microbial hosts (Kirby and Keasling 2009; Li and Pfeifer
2014), mostly employing Escherichia coli and yeast.
The production of terpenes using P. putida started with
biotransformation approaches, aiming to yield oxidation prod-
ucts of the plant monoterpene limonene which was supple-
mented to the process. These products are valuable for their
flavoring, antibiotic, and anticancer properties (Schrader
2007; Garcia et al. 2010). In one setup, a heterologously
expressed P450 was applied for the hydroxylation of (S)-lim-
onene to (S)-perillyl alcohol (Van Beilen et al. 2005;
Cornelissen et al. 2013). Other studies exploited the bacte-
rium’s intrinsic enzymes that naturally degrade p-cymene via
p-cumate. This three-step degradation involves enzymes also
active towards limonene and its respective oxidation products
perillyl alcohol and perillaldehyde, thereby converting limo-
nene to the monoterpenoid perillic acid (Speelmans et al.
1998; Mars et al. 2001; Mirata et al. 2009).
Full de novo biosynthesis of a monoterpenoid was demon-
strated recently (Mi et al. 2014). In this study, P. putida strain
DSM12264 was used for the production of geranic acid
(Fig. 1) which has received attention for potential applications
in fragrance and flavor industries (Schrader 2007). It was
achieved by expression of geraniol synthase from Ocimum
Fig. 2 Representative examples of natural products synthesized in P. putida. a Product structural formula; b biosynthetic genes needed to produce
compounds shown in a; numbering of gene clusters refers to compounds shown in a, asterisk indicates synthetic operons
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basilicum (basil) whose product geraniol was converted to
geranic acid by an intrinsic enzyme. The required C10 sub-
strate for the synthase is geranyl pyrophosphate (GPP). It is
provided by P. putida via the MEP (2-C-methylerythritol-4-
phosphate) isoprenoid biosynthesis pathway which starts
using pyruvate and glyceraldehyde-3-phosphate from central
metabolism and is the common pathway in most bacteria.
Yields were improved significantly by increasing the isoprene
precursor pool by coexpression of the six genes of the MVA
(mevalonate) isoprenoid biosynthesis pathway from the
myxobacterium Myxococcus xanthus DSM16526 (hmgs,
hmgr,mvk, pmvk,mvd, and idi). This way, a second route from
central metabolism (acetyl-CoA) to isoprenoid building
blocks was installed. All genes were assembled into a synthet-
ic operon (of about 8.5 kb) under control of the rhaPBAD
promoter from E. coli in one plasmid. In a lab-scale bioreactor
setup, 193 mg/l of geranic acid could be produced. Notably,
this is the first report showing feasibility of microbial produc-
tion of this compound in general. The product was for the
most part found in the supernatant, whereby downstream pro-
cessing is facilitated. Moreover, in associated toxicity tests,
the authors could show that P. putida exhibited tolerance to
significantly higher concentrations of the product than E. coli
and yeast. This underlines the potential of P. putida as produc-
tion host for monoterpenoids.
Bes ide s the s e examp le s fo r b io syn thes i s o f
monoterpenoids, recombinant production of tetraterpenes
was also established using P. putida. The production of the
yellow-colored xanthophyll carotenoid zeaxanthin (Fig. 2, 2),
which is relevant as food and feed additive and offers potential
in pharmaceutical applications (Baiao et al. 1999; Nishino
et al. 2009; Abdel-Aal et al. 2013), was reported by Beuttler
et al. (2011). Expression of five carotenoid biosynthesis genes
(crtEBIYZ) from the enterobacterium Pantoea ananatis
DSM30080 established the conversion of the C15 isoprenoid
precursor farnesyl pyrophosphate (FPP) to zeaxanthin. In ad-
dition, three genes from the E. coli MEP pathway (idi, ispA,
and dxs) were coexpressed in order to enhance metabolic flux
from C5 isoprenoid building blocks via GPP to FPP. All genes
were assembled in an expression vector as a synthetic operon
of about 8.5 kb under control of the rhaPBAD promoter and
expressed in P. putida KT2440. After optimization of cultiva-
tion conditions and media additives, 239 mg/l of zeaxanthin
could be produced. The same crt genes were used in another
study for heterologous zeaxanthin biosynthesis in P. putida
KT2440 (Loeschcke et al. 2013). Here, the applied transfer
and expression system named TREX enabled the direct ex-
pression of the bidirectional natural gene cluster by conver-
gent transcription from two T7 promoters, thereby
circumventing the need for genetic reengineering. Chromo-
somal integration of different deletion versions of the cluster
and subsequent T7 RNA polymerase-dependent expression
led to production of zeaxanthin and β-carotene. Notably, this
setup without engineered enhancement of the precursor pool
only generated yields at low milligram scale.
The suitability of P. putida as terpenoid producer is hard to
evaluate based on the low number of available studies. How-
ever, substantial yields of geranic acid and zeaxanthin suggest
a promising potential. Engineering of the supply of isoprene
precursors via the MEP or MVA pathway appears to be the
crucial factor for success here.
Polyketides/Non-ribosomal peptides
Polyketides and non-ribosomal peptides include a large and
extremely diverse group of natural compounds with various
highly valuable bioactivities such as antibiosis and cytotoxic-
ity. They share features in biosynthesis and often cooccur in
hybrid assembly systems (Wang et al. 2014). Briefly, the bio-
synthetic proteins of both assembly machineries catalyze the
condensation of simple building blocks, i.e., carboxylic or
amino acids, to produce polymer chains that can be cyclized
and decorated to form numerous natural products. Three dif-
ferent types of polyketide synthases (PKSs) produce carbonyl
polymers by condensing activated acyls (typically acetyl-CoA
and malonyl-CoA) (Shen 2003; Cummings et al. 2014): Type
I PKSs are large, highly modular proteins containing domains
which catalyze biosynthesis steps, whereas type II PKSs are
complexes of multiple individual proteins with dedicated
functions. In both types, the elongating polymer is handed
from one polymer extending module to the next, where it is
linked to the protein by thioester bonds. Type I and II systems
share features and nomenclature with fatty acid synthases.
Type III PKSs, also referred to as chalcone synthase-like
PKSs, are homodimeric enzymes that catalyze condensation
and cyclization reactions producing phenolic products. Non-
ribosomal peptide synthases (NRPSs) produce peptidyl poly-
mers by adenylation and subsequent condensation of amino
acids. Like in polyketide synthesis, the elongating polymer is
bound to the enzyme by a thioester bond. Similar to PKSs,
there are both modular multidomain NRPS enzymes and
NRPS enzyme complexes (Finking and Marahiel 2004;
Strieker et al. 2010).
Heterologous production of polyketides and non-ribosomal
peptides has been demonstrated employing a diverse set of
hosts, including fungi, Gram-positive bacteria, and Gram-
negative bacteria such as M. xanthus, E. coli, and P. putida
(Fujii 2009; Zhang et al. 2011; Ongley et al. 2013). For het-
erologous expression of the described systems, it is important
to consider that with exception of type III PKSs, PKSs and
NRPSs require their acyl carrier protein (ACP) and peptidyl
carrier protein (PCP) domains, respectively, to be
posttranslationally modified by a phosphopantetheinyl trans-
ferase (PPTase) in order to function. The genes for cognate
PPTases are often not part of the PKS/NRPS gene cluster.
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Notably, the predominantly used P. putida strain KT2440 pro-
vides a broad substrate range PPTase which is able to activate
both ACP and PCP domains (Gross et al. 2005; Owen et al.
2011) and is often more suitable than, e.g., E.coli PPTase,
which circumvents the constraints of additional introduction
of foreign PPTase genes.
Polyketides
The first polyketide heterologously produced in P. putida was
2,4-DAPG (2,4-diacetylphloroglucinol) (Fig. 2, 3) which has
received interest for its activity against plant pathogens
(Bakker et al. 2002; Haas and Défago 2005) and methicillin-
resistant Staphylococcus aureus (Kamei and Isnansetyo 2003).
A 6.5-kb DNA fragment from Pseudomonas fluorescens
ATCC 49323 containing the respective gene cluster was
inserted into the genome of P. putida KT2440 (Martinez
et al. 2004). It encompasses five unidirectionally organized
genes (phlACBDE), where PhlD is a type III polyketide syn-
thase catalyzing the synthesis of monoacetylphloroglucinol
from three molecules of malonyl-CoA, which is in turn con-
verted to 2,4-DAPG by the action of the other phl-encoded
enzymes (Bangera and Thomashow 1999; Achkar et al. 2005).
The expression of the genome-integrated phl cluster in
P. putida was presumably driven by its native promoters or
by chromosomal promoters adjacent to the insertion site. The
accumulation of 2,4-DAPG could be detected but was not
quantified.
Another type III PKS product, the UV protective pigment
(Zeng et al. 2012) flaviolin (2,5,7-trihydroxy-1,4-
naphthoquinone), could be synthesized in P. putida KT2440
(Gross et al. 2006a). Here, the 1.1-kb rppA gene from
myxobacterium Sorangium cellulosum So ce56 was
expressed from a plasmid using the m-toluate-inducible
Pm promoter f rom P. put ida . RppA, a 1 ,3 ,6 ,8-
tetrahydroxynaphthalene synthase (THNS), utilizes five
malonyl-CoA to synthesize THN, which is converted by
autooxidation to flaviolin. About 6 mg of the red colored
product could be purified from 1 l cell-free supernatant of
culture broth.
Non-ribosomal peptides
The earliest study showing the heterologous biosynthesis of a
non-ribosomal peptide in P. putida reports on the production
of the β-lactam antibiotic deacetyl-cephalosporin C (DAC).
P. putida IFO14164 was used for expression of the clustered
genes pcbABCcefEFD from the actinomycete Lysobacter
lactamgenus YK90 (Kimura et al. 1996). The 16-kb gene
region comprising five unidirectionally oriented genes was
expressed from a plasmid under control of Plac from E. coli.
The pcbAB gene encodes one protein comprising three NRPS
modules, which enabled the synthesis of LLD-ACV (δ-(L-α-
aminoadipyl)-L-cysteinyl-D-valine). The non-canonic amino
acid L-α-aminoadipic acid is derived from lysine and provided
by P. putida. By the action of the other cluster-encoded en-
zymes, LLD-ACV is converted to the antibiotic DAC via pen-
icillin N. DAC is naturally further differentiated to various β-
lactam products (Demirev et al. 2006; Hamed et al. 2013). The
L. lactamgenus specific end product cephabacin was not pro-
duced, since the hitherto required enzymes were excluded in
the study. The study did not focus on production yield; how-
ever, about 2 mg of DAC could be extracted from cell material
obtained from 1-l broth.
Recently, the biosynthesis of serrawettin W1 (Fig. 2, 4),
another NRPS-derived compound, could be established in
P. putida. This cyclic lipopeptide has gathered attention for
its biosurfactant properties as well as antimicrobial and anti-
tumor activities (Matsuyama et al. 2011; Kadouri and Shanks
2013). In order to produce the compound, the 4-kb swrW gene
from the enterobacterium Serratia marcescens DSM12481
was cloned in a vector under control of Ptac (Thies et al.
2014). The SwrW protein comprises the NRPS module re-
quired to produce the symmetrical serrawettin W1 molecule
consisting of two serine residues attached to two β-hydroxy
fatty acids via ester and amide bonds. Expression of swrW in
P. putida KT2440 enabled serrawettin W1 recovery from cul-
ture supernatant at milligram scale (S Thies, unpublished).
Polyketide/Non-ribosomal peptide hybrid compounds
The first product synthesized by a heterologously expressed
type I PKS/NRPS hybrid system in P. putida was
myxochromide S (Fig. 2, 5) (Wenzel et al. 2005). To this
end, the 30-kb mchABC cluster from Stigmatella aurantiaca
DW4/3-1 was introduced into P. putida KT2440. The PKS
module which utilizes acetyl-CoA, malonyl-CoA, and
propionyl-CoA is encoded in mchA, while mchB encodes a
two-module NRPS and mchC a four-module NRPS (one of
those being skipped in biosynthesis), together forming the
peptide part from alanine, glutamine, threonine, and leucine.
The unidirectional gene cluster was inserted into the host chro-
mosome at the anthranilate synthase gene trpE by homolo-
gous recombination. Expression of mch genes and thus accu-
mulation of the yellow-orange colored myxochromide S in
P. putida cells was implemented using them-toluate-inducible
Pm promoter. Notably, lowering of expression temperature
from 30 to 16 °C after induction resulted in a 1000-fold in-
crease of production to 40 mg/l. Supply of malonyl-CoAwas
identified as yield-limiting bottleneck that might be addressed
in future studies to increase myxochromide production
(Stephan et al. 2006).
Another myxobacterial type I PKS/NRPS hybrid system
from S. aurantiaca DW4-3/1 expressed in P. putida resulted
in the production of myxothiazol A (Fig. 2, 6) (Perlova et al.
2006; Gross et al. 2006b), an inhibitor of the respiratory chain
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with antifungal and insecticidal activities (Clough 1993). The
60-kb mta gene cluster (mtaBCDEFG) was inserted into the
chromosome of P. putida by the same method as the
abovementioned mch cluster in gene trpE. While MtaB,
MtaE, andMtaF are PKS parts andMtaC andMtaG are NRPS
modules, the gene mtaD encodes a hybrid protein containing
both PKS and NRPS modules. The PKS parts employ
isovaleryl-CoA, which is provided by P. putida from the deg-
radation of leucine, as the starter unit, and acetyl-CoA as well
as methylmalonyl-CoA (mm-CoA) as extender units. The
NRPS modules incorporate the amino acids cysteine and gly-
cine (Perlova et al. 2006). Since P. putida does not intrinsically
synthesize mm-CoA, the bacteriumwas engineered to provide
the necessary precursor from its succinyl-CoA pool. This was
achieved by expression of an operon from S. cellulosum So
ce56 encoding mm-CoA epimerase (epi), mm-CoA mutase
(mcm), and an MCM complex protecting protein (meaB) that
was integrated in the chromosome. Expression of the mm-
CoA operon was executed either by coexpression with the
host genes at the integration site and/or driven by the promoter
of a neomycin resistance gene which was coinserted. Expres-
sion of the myxothiazol cluster using the Pm promoter result-
ed in minor production levels. Product formation was in-
creased to 0.6 mg/l by feeding of leucine and vitamin B12.
Both the vitamin, required as cofactor for mm-CoA mutase,
and the precursor leucine are intrinsically synthesized by
P. putida but nevertheless appear to be limiting factors in
product formation.
Via expression of the tubulysin gene cluster from the
myxobacterium Cystobacter sp. SBCb004, a further type I
PKS/NRPS hybrid system, was successfully installed in
P. putida (Chai et al. 2012). The applied ~40 kb gene cluster
comprised 11 genes, namely the unidirectional core assem-
bly line part tubBCDEF as well as tubA, tubZ, orf2, orf1,
orf17, and orf18 organized around it (Sandmann et al.
2004). While TubB, TubC, and TubE are NRPS parts and
TubF is a PKS part, TubD is a PKS/NRPS hybrid protein.
First, TubZ produces pipecolic acid from lysine, which is
then methylated and used as starter unit N-methyl-pipecolic
acid byTubB.Byextensionwith isoleucine, valine, cysteine,
and tyrosine or phenylalanine as well as two molecules of
acetyl-CoA, the core pretubulysin is formed, which is natu-
rally further decorated by oxidation and acylation reactions.
Similar to tubulysin, pretubulysin exhibits also highly valu-
able activities inducing apoptosis and inhibiting cancer cell
migration and tubulin assembly in vitro and in vivo (Herr-
mann et al. 2012; Braig et al. 2014). The tub cluster was
inserted into the chromosome of P. putida using the
MycoMar transposon and was expressed relying on the na-
tive promoter(s) and by additional insertion of the Ptet pro-
moter from transposon Tn10 in front of tubCDEF. This re-
sulted in the production of the two variants pretubulysin A
(Fig. 1) and tyrosine pretubulysin A (a product of module
skipping). Yields could be pushed eightfold to 1.76 μg/l by
supplementing pipecolic acid. Interestingly, in contrast to
observations made with myxochromide S, yields of
pretubulysin A were doubled at 30 °C compared to 16 °C
cultivation temperature.
Two members of the syrbactin group that are synthesized
by type I PKS/NRPS hybrid systems (Dudler 2014) were pro-
duced in P. putida P3. The compounds have received particu-
lar attention for their ability to inhibit proteases and induce
apoptosis in different cancer cell lines such as neuroblastoma
(Archer et al. 2010). Syringolin A (Fig. 2, 7) was produced by
expression of the sylABCDE cluster from Pseudomonas
syringae pv. syringae (Ramel et al. 2009). The biosynthesis
core is constituted by sylC encoding an NRPS module and
sylD encoding two NRPS modules and one PKS module.
Syringolin A is synthesized from valine which is joined to a
second molecule valine by an unusual ureido group, 3,4-
dehydrolysine, another valine and malonyl-CoA. SylB is
thought to act as desaturase converting lysine to 3,4-
dehydrolysine, while sylA and sylE encode a putative tran-
scription activator and the exporter of syringolin. The 22-kb
gene region was expressed from a cosmid relying on the orig-
inal promoters. Produced syringolin Awas recovered from the
medium, corroborating functionality of the syringolin export-
er encoded in the cluster. Glidobactin A was produced by
expression of the homologous plu1881–1877 gene cluster
from Photorhabdus luminescens subsp. laumondii TT01
(Dudnik et al. 2013). The biosynthesis core in the 18.3-kb
cluster consists of NRPS encoding plu1878 (sylC homolog)
and NRPS/PKS encoding plu1880 (sylD homolog). In
glidobactins, the ureido-valyl moiety typical for syringolin is
replaced by a fatty acid tail attached to the starter amino acid
threonine. Glidobactin A biosynthesis proceeds by incorpora-
tion of lysine, which is modified by 4′-hydroxylation, alanine,
and malonyl-CoA. Remarkably, heterologous production in
P. putida was successful in unagitated cultures, grown for
5 days. Determination of product yields was not in focus of
the study.
Prodigiosin (Fig. 2, 8) represents a metabolite derived from
a biosynthesis pathway very different from the typical NRPS/
PKS assembly lines but still related via some shared motives
in the involved enzymes. The red colored tripyrrolic pigment
with highly valuable bioactivities such as antibiosis and cyto-
toxicity (Hassankhani et al. 2014; Lapenda et al. 2014) is
synthesized from 2-octenal, pyruvate, proline, malonyl-CoA,
and serine in a complex bifurcated pathway, whose two prod-
ucts are condensed in a final reaction to form prodigiosin
(Williamson et al. 2006). In S. marcescensW838, the pathway
is encoded in the 22-kb pigABCDEFGHIJKLMN cluster.
PigA, PigG, PigH, PigI, and PigJ act together as an NRPS/
PKS assembly line producing a chain from proline, malonyl-
CoA, and serine (Garneau-Tsodikova et al. 2006). Application
of the TREX expression system enabled identification of
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P. putida KT2440 as a promising producer by chromosomal
integration and PT7-dependent expression of the pig gene clus-
ter, yielding 0.5 mg/g cell dry weight (CDW) of prodigiosin
(Loeschcke et al. 2013). Based on that, the group evaluated a
different expression setup, pushing yields by 2 orders of mag-
nitude (Domröse et al., unpublished) and proving the capabil-
ity of P. putida for high-level production of the interesting
metabolite. Here, the expression strategy appeared to be cru-
cial for increasing yields.
The general capability ofP. putida to synthesize PKS/NRPS
products is undisputed as documented by the here provided list
of successful examples. As mentioned above, the bacterium’s
features such as its PPTase and xenobiotic tolerance render it
especially suitable for the production of this group of com-
pounds. Thus, use of P. putida for expression of PKS/NRPS
systems can be considered as a valuable option for the identi-
fication of high-value compounds and the elucidation of their
biosynthetic pathways. However, yields are often low and
compounds are too diverse to recommend a general strategy
for improvement. Considering the large gene clusters encoding
biosynthesis, the expression strategy is surely a dominant bot-
tleneck. On the level of biosynthesis, it is worth underlining
that in some cases, cultivation conditions significantly influ-
enced production, apparently in a highly product-specific man-
ner. Optimal conditions thus have to be evaluated experimen-
tally. Since several studies report increased yields if precursors
are supplemented, engineering approaches to enhance precur-
sor supply may in the future improve production.
Further products from amino acid metabolism
Aromatic compounds
The extraordinary tolerance of P. putida S12 towards organic
solvents (Weber et al. 1993; Kuepper et al. 2015) enabled its
application in the production of various aromatic compounds
valuable as building blocks for bioactive small molecules,
resins, and polymers (Meijnen et al. 2011a). Here, shikimate
pathway-derived amino acids are utilized as precursors
(Gosset 2009).
In contrast to many of the compounds described in this
review, introduction of only one or two enzymes instead of
whole operons or gene clusters into P. putida is sufficient for
the production of aromatics. Accumulation of diverse prod-
ucts was implemented by additionally targeted control of the
host’s intrinsic metabolic inventory by deletion of genes at
different stages of aromatics catabolism. This way, several
aromatics producers were generated and developed from one
another. An excellent overview on the genealogy of the strains
applied for production of aromatics is given by Tiso et al.
(2014). The relevant studies are summarized briefly in the
following.
First, t-cinnamate and phenol producer strains were gener-
ated by introduction of the phenylalanine/tyrosine ammonia
lyase gene pal from Rhodosporidium toruloidesATCC 64815
and the tyrosine phenol lyase gene tpl from Pantoea
agglomerans AJ2985, respectively (Nijkamp et al 2005;
Wierckx et al 2005). Heterologous expression of these key
biosynthetic enzymes was controlled by the salicylate-
inducible promoter system NagR/PnagAa from Comomonas
testosteroni (tpl) or Ptac (pal) and resulted after further strain
improvement by chemical mutagenesis in production strains
that accumulated extracellularly 5.4 mM (0.8 g/l) t-cinnamate
and 9.2 mM (0.9 g/l) phenol, respectively.
Based on the abovementioned two chassis strains, pro-
ducers of further aromatic compounds were constructed.
Nijkamp et al. (2007) enhanced metabolic flux towards tyro-
sine and introduced phenylalanine auxotrophy by randommu-
tagenesis of the t-cinnamate producer strain. Additional dele-
tion of the feruloyl-CoA synthetase gene fcs whose product
catalyzes the first step of p-coumarate degradation led to an
effective production strain accumulating p-coumarate (Fig. 1)
instead of t-cinnamate in amounts of up to 1.7 g/l.
A p-hydroxystyrene producer was constructed by addition-
al introduction of the p-coumaric acid decarboxylase gene pdc
from Lactobacillus plantarum DSM20174 into the fcs-defi-
cient pal expressing chassis strain with yields up to 21 mM
(2.5 g/l) with expression of pal and pdc under NagR/PnagAa
control (Verhoef et al. 2009). Accumulation of p-
hydroxybenzoate up to 1.8 g/l was achieved by Verhoef et al.
(2007) via replacement of the tpl expression vector in the
phenol producer strain by a pal expression vector and deletion
of pobA in the host’s genome. The latter gene product cata-
lyzes the first step in p-hydroxybenzoate degradation. As a
result, Pal-synthesized p-coumarate was converted by
P. putida S12 intrinsic metabolic pathways to p-
hydroxybenzoate, which was not further degraded. Compari-
son of transcriptome data from the producer strain with the
wild-type P. putida S12 identified the multidrug efflux MFS
transporter PP1271–PP1273 to play an important, but not es-
sential, role in p-hydroxybenzoate secretion. Furthermore, the
4-hydroxyphenylpyruvate dioxygenase encoding gene hpd as
a target for further strain improvement. Deletion of hpd en-
hanced metabolic flux towards the product and led to an in-
crease in yield from 0.25 to 0.31 g/l (2.3 mM) in the applied
experimental setup by Verhoef et al. (2010). Targeted engi-
neering of precursor supply for aromatic molecules via the
pentose phosphate pathway was achieved by introduction of
the E. coli DH5α xylose degradation genes xylAB_FGH. The
respective enzymes channeled xylose into the pathway which
resulted in yields increased by further 22 % and moreover
enabled production of these compounds from plant biomass
(Meijnen et al. 2011a, 2011b).
The listed examples and convincing yields show the poten-
tial for P. putida-based industrial production processes.
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Besides engineered enhancement of the precursor pool, ran-
dom chemical mutagenesis, and subsequent application of
feasible screening strategies proved to be excellent tools for
simple generation and identification of strains with improved
aromatics production (Tiso et al. 2014). In some of the men-
tioned studies, optimal yields of aromatics were obtained by
application of two-phase systems which combine the culture
medium with an organic solvent for immediate removal of
toxic aromatic products, a technique for which P. putida S12
is especially suited due to its remarkable solvent tolerance
(Heipieper et al. 2007, Verhoef et al. 2009).
Aromatic amino acid-derived metabolites other than phe-
nolic compounds that were produced in P. putida are N-acyl
aromatic amino acids, a class of secondary metabolites with
antimicrobial activity that was initially discovered by screen-
ing of metagenomic libraries for compounds capable of
inhibiting Bacillus subtilis. Active expression of the biosyn-
thetic machinery with the key enzymes from the N-acyl amino
acid synthase family from a 29-kb environmental DNA frag-
ment and secretion of the product was reported for P. putida
KT2440 (Craig et al. 2010). In the same study, introduction of
environmental DNAwas sufficient to induce increased intrin-
sic production of porphyrine-derived pigments in clones of a
metagenomic library in P. putida. Therefore, the authors con-
clude that P. putida has a high potential in metagenome-based
studies concerning the detection of novel secondary metabo-
lites. Considering that P. putida does not intrinsically produce
antibiotics but exhibits extraordinary tolerance to producing
such compounds, it may prove especially useful in functional
screenings for novel antimicrobials. This potential is yet to be
exploited. Further reports support the idea of P. putida as an
alternative host for functional screening of metagenomics li-
braries (Troeschel et al. 2012; Liebl et al. 2014).
Likewise an aromatic amino acid derivative is the bacterial
pigment deoxyviolacein (Fig. 2, 9). It is formed from two
molecules of tryptophan and described to show dyeing and
antimicrobial properties (Xing and Jiang 2011; Jiang et al.
2012). This derivative of violacein was accumulated in
P. putida mt-2 at levels of 1.5 g/l dependent on expression
of vioABCE, an engineered variant of the violacein biosynthe-
sis operon vioABCDE from Duganella sp. B2, controlled by
the alkane-inducible alKB promoter from P. putida (Xing and
Jiang 2011).
In bacteria, the shikimate pathway provides precursors like
chorismate not only for mentioned aromatic amino acids but
also for different carbocyclic aromatic secondary metabolites
like phenazines. These often antimicrobial redox mediators
fulfill different functions, e.g., to support virulence and com-
petitive fitness of the producing organisms. Due to their anti-
bacterial and antifungal properties, phenazine derivatives are
of interest for pharmaceutics and biocontrol (Pierson and
Pierson 2010; Jayaseelan et al. 2014). Glandorf et al. (2001)
modified the plant growth promoting P. putida strain
WCS358r to produce the yellow pigment PCA (phenazine1-
carboxylic acid) by Ptac-controlled expression of the genome-
integrated phzABCDEFG operon from P. fluorescens 2-79.
Thereby, the host strain was turned into an improved fungal
growth-inhibiting biocontrol strain (Glandorf et al. 2001;
Bakker et al. 2002; Viebahn et al. 2005). Recently, production
of PCA and its subsequent conversion to pyocyanin (Fig. 2,
10) was established in KT2440 by simultaneous expression of
phzA1B1C1D1E1F1G1 and phzMS from P. aeruginosa PAO1
on two compatible plasmids (Schmitz et al. 2015), yielding
45 mg/l pyocyanin. Remarkably, accumulating the recombi-
nant redox mediator in the culture medium enabled P. putida
to sustain strongly oxygen-limited culture conditions by redox
balancing via an anode as electron acceptor.
These examples suggest P. putida to be a suitable host for
production of aromatic pigments with antimicrobial activity in
future studies.
Non-aromatic compounds
Besides these examples for utilization of aromatic amino acids
or their precursor molecules, it was demonstrated that other
amino acids provided by the bacterium’s metabolism can also
serve as precursors for different natural products.
Monoethanolamine (MEA) is an alkanolamine extensively
used, e.g., to prevent corrosion, as a detergent, as a precursor
for the production of ethylamines, or for CO2 capture (Aaron
and Tsouris 2005; Foti et al. 2013). Currently, most MEA is
produced from petroleum feedstock. A sustainable alternative
was offered by production of MEA in the solvent tolerant
P. putida S12 strain via decarboxylation of serine (Foti et al.
2013). To this end, the authors introduced L-serine decarbox-
ylase (sdc) genes from Arabidopsis thaliana (ecotype Colum-
bia) and Vibrio carteri f. nagariensis. Efficient formation of
MEA was only observed with a truncated version of
A. thaliana Sdc. Strain improvement by deletion of genes
for MEA breakdown (eutBC) and media optimization led to
yields up to 0.2 g/l (2.6 mM in culture medium).
Cyanophycin is a polymer consisting of arginine and
aspartic acid, which was initially discovered in cyanobacteria
(Frommeyer et al. 2014). Compounds derived thereof have
gained interest for their applicability in technical processes
and as pharmaceuticals (Mooibroek et al. 2007; Steinbüchel
and Sallam 2010). Consequently, several studies aimed at re-
combinant production to achieve improved biotechnological
access to this polyamide (Frommeyer et al. 2014). P. putida
KT2440 was first used for constitutive expression of the
cyanophycin synthetase cphA from Synechocystis sp. strain
PCC6308. In mineral salt medium supplemented with aspartic
acid and arginine, the product could be accumulated to 11 %
of CDW. However, the obtained polymer exhibited reduced
length and polydispersity compared to the authentic material
from cyanobacteria (Aboulmagd et al. 2001). Voss et al.
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(2004) expressed cphA from further cyanobacterial strains in
KT2240 as well as GPp104, which resulted in the accumula-
tion of cyanophycins to amounts between 6.8 and 24 % of
CDW in mineral media. Highest yields were achieved by ex-
pressing the cyanophycin synthetase of Anabena sp. strain
PCC72120. GPp104 being deficient for the production of
the intrinsic polymer PHA (see above) accumulated in general
slightly higher amounts than the wild type during expression
of any CphA. Interestingly, substitution of arginine residues
by lysine within the polymer up to 10 mol% was observed in
case of cphA6308, if arginine was not supplemented to the
mineral medium. Another modified variant of cyanophycin
with citrulline partially substituting arginine was produced
by choosing the citrulline accumulating strain P. putidaATCC
4359 as expression host (Wiefel et al. 2011). Optimization of
culture conditions resulted in total amounts of citrulline-
containing cyanophycin of 43.4 % of CDW. Partial substitu-
tion of arginine by other amino acids like lysine or citrulline
was shown to lead to increased solubility of the naturally
largely insoluble polymer (Frommeyer and Steinbüchel
2013).
Perspectives
P. putida has been biotechnologically domesticated by con-
certed efforts of different fields of modern microbiology,
especially over the last decade. The here given overview of
natural products that could be synthesized by heterologous
gene expression demonstrates the bacterium’s potential in this
context. Synthetic biology further spurs these developments:
Recent studies reporting a genome-edited P. putida strain pro-
vide a robust next-generation cell factory with enhanced fea-
tures regarding genetic stability as well as energy state and
availability of reduction equivalents for future studies (Martí-
nez-García et al. 2014b; Lieder et al. 2015). Furthermore,
liberation ofP. putida from its obligate aerobic nature has been
reported, providing the basis for bioreactor-based processes
without aeration and allowing natural product formation by
oxygen-sensitive biocatalysts (Nikel and de Lorenzo 2013;
Schmitz et al. 2015). Engineering the bacterium for efficient
utilization of lignin-derived aromatics and xylose expanded
the spectrum of applicable carbon sources and enables the
utilization of plant biomass (Meijnen et al. 2011a; Meijnen
et al. 2012; Johnson and Beckham 2015). In such advanced
cell factories (Fig. 3), novel cloning and expression technolo-
gies will allow implementation of various biosynthetic pro-
duction pipelines, further expanding P. putida’s product port-
folio (Zhang et al. 1998; Fu et al. 2008, Gibson 2011; Martí-
nez-García and de Lorenzo 2011; Fu et al. 2012 Martínez-
García and de Lorenzo 2012; Loeschcke et al. 2013;
Durante-Rodríguez et al. 2014; Martínez-García et al.
2014a). By in-depth analysis of the bacterium’s carbon me-
tabolism as well as application of available Bomics^ tools, a
Fig. 3 Perspectives in P. putida research and application. Newly
developed sophisticated strain engineering and expression tools will
generate next-generation designed P. putida cell factories able to
convert various renewable substrates into a wealth of desired
compounds with high precision and efficiency. This may enable highly
diverse applications in the future: P. putida may be utilized for the
identification and elucidation of natural product pathways as well as for
the biotechnological production of high-value compounds. At the
interface of synthetic microbiology and medicine, pharmaceutical
application, e.g., of its outer membrane vesicles is suggested. Further,
the bacterium may be applied in an ecological and agricultural context
for remediation of soil, plant growth promotion, and biocontrol
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systems biology perspective will provide the basis for
knowledge-based metabolic engineering of P. putida in order
to increase yields of natural products (Nogales et al. 2008;
Puchałka et al. 2008; Wu et al. 2011; Sudarsan et al. 2014;
Simon et al. 2014). This ever-accelerating development in
methodology and knowledge gain paves the way for the re-
search to come in the field of natural product biosynthesis with
P. putida.
Future opportunities for application of P. putida may in-
clude the production of valuable compounds, but also the use
as delivery system for a variety of bioactive molecules
(Fig. 3). In this context, the bacterium’s outer membrane ves-
icles are discussed for their potential as adjuvants or vaccine
carriers due to their low pathological activity (Choi et al.
2014). Furthermore, based on release of intrinsically or
recombinantly produced compounds, it was suggested to ap-
ply P. putida for plant growth promotion and protection of
plants from disease as biocontrol agent (Bakker et al. 2002;
Glick 2012). Likewise, potential application of engineered
P. putida in the context of soil remediation via delivery of
suitable metabolites or enzymes was pointed out (de Lorenzo
2008; Cao et al. 2012; Chen et al. 2013).
Such studies demonstrate the potential of P. putida in high-
ly diverse fields of application and may inspire further excit-
ing developments towards the establishment of P. putida as a
platform for production of various natural products in the
future.
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